SACRAMENTO, California — California will start selling low-cost insulin in January, becoming the first state in the nation to bypass Big Pharma with its own supply of the expensive diabetes drug and ...
A peer-reviewed article by researchers at the University of Shanghai for Science and Technology (USST), published in an international biomedical engineering journal, reports that the Hextra Tech(TM) ...
CHAMBERS COUNTY, Texas – The sentencing phase will resume on Thursday after jurors found Sarah Hartsfield guilty of murdering her husband in 2023, after hearing nearly two hours of closing arguments ...
California will begin selling long-acting, low-cost insulin in January, becoming the first state to bypass major pharmaceutical companies, Gov. Gavin Newsom (D-CA) announced Thursday. The move marks a ...
Gov. Gavin Newsom speaks during a news conference announcing $11 insulin and prescription drugs with the CalRx program inside a Cedars-Sinai pharmacy in Los Angeles on Thursday. The effort is part of ...
California’s CalRx insulin pens will launch Jan. 1 at $11 each, or $55 for a five-pack The state has invested $100 million to lower insulin costs The effort could save patients $2,000 to $4,000 a year ...
Travel Noire on MSN
Wheels Up, Insulin Packed: How To Travel Boldly With Diabetes
Since her 2021 diabetes diagnosis, Stephanie Guignard, a nurse practitioner, has made it her mission to educate people on how ...
For many elderly diabetics, daily insulin injections become harder to manage with age-related cognitive decline. Missed doses ...
California Gov. Gavin Newsom announces CalRx-branded insulin glargine pens available next Jan. 1, 2026, at a suggested retail price of no more than $55 per five-pack, or $11 per pen, during a news ...
LOS ANGELES (AP) — Gov. Gavin Newsom said Thursday that California will begin selling affordable insulin under its own label on Jan. 1, nearly three years after he first announced a partnership to ...
Youth with type 1 diabetes experience better glycemic control with prolonged use of automated insulin delivery systems than with standard insulin regimens, according to a meta-analysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback